Last updated on November 2019

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)


Brief description of study

The purpose of the study is to document the natural history of hemophilia A disease and long-term outcomes in terms of effectiveness, safety and quality of life in participants receiving Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM) or Antihemophilic Factor (Recombinant) - Pegylated (rAHF-PEG) in routine clinical practice

Clinical Study Identifier: NCT02078427

Find a site near you

Start Over